HNGE HINGE HEALTH CLASS A
Information Technology · Russell 2000
Next earnings: not announced yet
What 21 analyst firms say about HINGE HEALTH CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
20 rated views · 21 analyst/firm records · 21 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8056
- Russell 2000 · Safest consensus · 6MGood · #37 in the index82
Recent analyst activity · last 90 days
Our tracked history has 24 reports on HNGE from 17 analyst firms in the last 90 days (21 firms in the past year).
Comparing each firm's latest target with its previous one: 13 raised their price target and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Canaccord Genuity raised its target from $105.00 (set 5 Aug 2026) to $134.00 on 3 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Vikram Kesavabhotla | Hold | 22 Sep 2026 | 90.00 USD |
| Bank of America Securities | Unnamed analyst | Buy | 29 Sep 2026 | 110.00 USD |
| Barclays | Saket Kalia | Buy | 12 Oct 2026 | 110.00 USD |
| Canaccord Genuity | Richard Close | Buy | 3 Nov 2026 | 134.00 USD |
| Citigroup | Unnamed analyst | Buy | 27 Jul 2026 | — |
| Citizens JMP | Aaron Kimson | Buy | 5 Aug 2026 | 107.00 USD |
| Evercore ISI | Elizabeth Anderson | Buy | 5 Oct 2026 | 125.00 USD |
| Freedom Capital | Unnamed analyst | Buy | 22 Jan 2026 | — |
| Freedom Capital Markets | Gene Mannheimer | Buy | 10 Aug 2026 | Conflicting reports · excluded |
| KeyBanc Capital Markets | Scott Schoenhaus | Buy | 16 Oct 2026 | 140.00 USD |
| Morgan Stanley | Craig Hettenbach | Buy | 13 Jul 2026 | 108.00 USD |
| Needham | Ryan MacDonald | Buy | 30 Sep 2026 | Conflicting reports · excluded |
| Piper Sandler | Jessica E Tassan | Buy | 5 Aug 2026 | 140.00 USD |
| Raymond James | Brian Peterson | Buy | 2 Nov 2026 | 138.00 USD |
| RBC Capital Markets | Rishi Jaluria | Buy | 3 Nov 2026 | 135.00 USD |
| Stifel | David Grossman | Buy | 26 Oct 2026 | 130.00 USD |
| Truist | Jailendra Singh | Buy | 3 Nov 2026 | 145.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Stan Berenshteyn | Buy | 5 Aug 2026 | Conflicting reports · excluded |
| William Blair | Ryan S Daniels | Buy | 3 Nov 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 11 Aug 2026 | 104.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:40 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.